Keywords: Ranbaxy, Nippon Chemiphar, Joint venture disolved, Generics, Japan

Nippon Chemiphar to take full control of Japanese JV with Ranbaxy

Article | 08 December 2009

India’s largest drugmaker Ranbaxy Laboratories (which is 63.9%-owned by Japan's Daiichi Sankyo) and Nippon Chemiphar plan to dissolve their 50/50 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Daiichi Sankyo

Ranbaxy Laboratories

Sankyo

Drug Discovery

Go to company listing